why choose us

First received: December 19, 2024

Clinical Trial: Test-retest Study With [18F]FBB in Cardiac Amyloidosis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Cardiac Amyloidosis

Study Type: INTERVENTIONAL


Official Title: A Test-retest Study to Evaluate the Reproducibility of [18F]Florbetaben PET Imaging in Patients With Cardiac Amyloidosis and Control Patients

Brief Summary: This study is an open-label study to evaluate and characterize test-retest reliability of \[18F\]florbetaben PET in subjects with AL-CA and ATTR-CA compared to non-CA subjects. Quantification of the \[18F\]florbetaben parameters related to the deposition of amyloid in the heart (such as Myocardial Tracer Retention (MTR) or Retention Index (RI)), and the variability in these parameters after repeated imaging will be evaluated. Measurement of blood metabolites and comparison of invasive with non-invasive…

Read more